University of Vermont

Grantee website Burlington, Vermont, United States
Purpose
to accelerate the development of therapeutics and vaccines by formalizing an experimental medicine model of Cryptosporidium hominis, the most prevalent cause of human cryptosporidiosis, that can be used to test candidate therapeutics and vaccines
Division
Global Health
Date
NOVEMBER 2015
Region served
GLOBAL
Committed amount
$1,049,846
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
40
Grantee location
Burlington, Vermont, United States

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.